(Total Views: 134)
Posted On: 09/09/2020 11:55:49 AM
Post# of 27336

$CLRB News Article - Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients https://marketwirenews.com/news-releases/cell...87221.html


My Twitter: WhyteStocks